Literature DB >> 10221706

Reproductive capacity of round spermatids compared with mature spermatozoa in a population of azoospermic men.

I M Ghazzawi1, S Alhasani, M Taher, S Souso.   

Abstract

The present study aims to evaluate the injection of testicular round spermatids from patients with complete failure of spermiogenesis compared with that of mature epididymal and testicular spermatozoa. Over a period of 8 months, 188 azoospermic patients were evaluated with a view to their inclusion in our intracytoplasmic sperm injection (ICSI) programme. All patients had had a previous testicular biopsy; 38 had pure obstructive azoospermia, while 150 had non-obstructive azoospermia. Mature spermatozoa were found in 93 patients, whereas spermatozoa were entirely absent, with a predominance of round spermatids in 87. In eight patients, spermatids could not be found and therefore their cycles were cancelled. There was an early appearance of the two pronuclei stage in the round spermatid group compared with the mature spermatozoa group of patients (10.2 and 16 h respectively). The fertilization rate was also significantly lower (P = 0.00001) in the round spermatid group. The numbers of embryos developed and of embryo transfers in the round spermatid injection group were significantly lower compared with the mature spermatozoa injection group (P = 0.05 and 0.0001 respectively). No pregnancies resulted from round spermatid injection, while 18 pregnancies were achieved from the injection of mature spermatozoa. In conclusion, injection of round spermatids from patients with complete failure of spermiogenesis resulted in a significantly lower fertilization rate and a higher developmental arrest compared with injection of mature spermatozoa. With no pregnancies achieved, one may question the unusual variability of reported success rates and stress the need for further research in order to improve the outcome of this novel technique.

Entities:  

Mesh:

Year:  1999        PMID: 10221706     DOI: 10.1093/humrep/14.3.736

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  8 in total

1.  Intracytoplasmic injection using spermatids and subsequent pregnancies: round versus elongated spermatids.

Authors:  Mohammad A Khalili; Abbas Aflatoonian; Panos M Zavos
Journal:  J Assist Reprod Genet       Date:  2002-02       Impact factor: 3.412

2.  Development of blastocyst-stage embryos after round spermatid injection in patients with complete spermiogenesis failure.

Authors:  K Vicdan; A Z Isik; L Delilbaşi
Journal:  J Assist Reprod Genet       Date:  2001-02       Impact factor: 3.412

3.  Effect of testicular morphology on embryo development to the blastocyst stage after round spermatid injection.

Authors:  Gokhun Ozmerdiven; Yavuz Guler; Eren Sahin; Zeynep Tatar; Akif Erbin; Ebubekir Dirican; Ahmet Hakan Haliloglu
Journal:  Am J Clin Exp Urol       Date:  2021-12-15

Review 4.  Is intracytoplasmic sperm injection safe? Current status and future concerns.

Authors:  D M Nudell; L I Lipshultz
Journal:  Curr Urol Rep       Date:  2001-12       Impact factor: 3.092

Review 5.  The present status of artificial oocyte activation in assisted reproductive technology.

Authors:  Kaoru Yanagida; Yoko Fujikura; Haruo Katayose
Journal:  Reprod Med Biol       Date:  2008-08-03

6.  The Novel Key Genes of Non-obstructive Azoospermia Affect Spermatogenesis: Transcriptomic Analysis Based on RNA-Seq and scRNA-Seq Data.

Authors:  Haihong He; Fan Yu; Wang Shen; Keyan Chen; Lijun Zhang; Shuang Lou; Qiaomin Zhang; Siping Chen; Xinhua Yuan; Xingwang Jia; Yiwen Zhou
Journal:  Front Genet       Date:  2021-02-26       Impact factor: 4.599

Review 7.  Genetic causes of male infertility: current concepts.

Authors:  D M Nudell; P J Turek
Journal:  Curr Urol Rep       Date:  2000-12       Impact factor: 2.862

8.  Round spermatid injection into human oocytes: a systematic review and meta-analysis.

Authors:  Brent M Hanson; Taylor P Kohn; Alexander W Pastuszak; Richard T Scott; Philip J Cheng; James M Hotaling
Journal:  Asian J Androl       Date:  2021 Jul-Aug       Impact factor: 3.285

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.